Benzinga | Mar 18, 2021 07:07AM EDT

ADC Therapeutics Q4 EPS $(0.82) Misses $(0.38) Estimate

ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(0.82) per share which missed the analyst consensus estimate of $(0.38) by 115.79 percent.